These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27109343)

  • 21. [TNF-α activates Wnt signaling pathway to promote the invasion of human colon cancer stem cells].
    Wei X; Li X; Kong F; Ma L; Sui Y; Chen D; Xu F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Nov; 34(11):982-988. PubMed ID: 30591106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
    Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
    Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin inhibits tumor epithelial‑mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells.
    Zhang Z; Chen H; Xu C; Song L; Huang L; Lai Y; Wang Y; Chen H; Gu D; Ren L; Yao Q
    Oncol Rep; 2016 May; 35(5):2615-23. PubMed ID: 26985708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-kappaB in colon cancer cell lines.
    Nakagawa Y; Akao Y
    Exp Cell Res; 2006 Aug; 312(13):2433-42. PubMed ID: 16733051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NF-κB affects proliferation and invasiveness of breast cancer cells by regulating CD44 expression.
    Smith SM; Lyu YL; Cai L
    PLoS One; 2014; 9(9):e106966. PubMed ID: 25184276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of epithelial‑mesenchymal transition in gastric cancer cells by miR‑711‑mediated downregulation of CD44 expression.
    Xiao WS; Li DF; Tang YP; Chen YZ; Deng WB; Chen J; Zhou WW; Liao AJ
    Oncol Rep; 2018 Nov; 40(5):2844-2853. PubMed ID: 30226620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging prognostic markers related to mesenchymal characteristics of poorly differentiated breast cancers.
    Scimeca M; Antonacci C; Colombo D; Bonfiglio R; Buonomo OC; Bonanno E
    Tumour Biol; 2016 Apr; 37(4):5427-35. PubMed ID: 26563370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lithium chloride induces mesenchymal‑to‑epithelial reverting transition in primary colon cancer cell cultures.
    Costabile V; Duraturo F; Delrio P; Rega D; Pace U; Liccardo R; Rossi GB; Genesio R; Nitsch L; Izzo P; De Rosa M
    Int J Oncol; 2015 May; 46(5):1913-23. PubMed ID: 25738332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
    Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
    World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas.
    Völp K; Brezniceanu ML; Bösser S; Brabletz T; Kirchner T; Göttel D; Joos S; Zörnig M
    Gut; 2006 Feb; 55(2):234-42. PubMed ID: 16118352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and function of NIK- and IKK2-binding protein (NIBP) in mouse enteric nervous system.
    Zhang Y; Bitner D; Pontes Filho AA; Li F; Liu S; Wang H; Yang F; Adhikari S; Gordon J; Srinivasan S; Hu W
    Neurogastroenterol Motil; 2014 Jan; 26(1):77-97. PubMed ID: 24011459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transition.
    Li Q; Bao W; Fan Q; Shi WJ; Li ZN; Xu Y; Wu D
    Mol Med Rep; 2016 Oct; 14(4):3220-8. PubMed ID: 27573546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.
    Zhang Z; Bu X; Chen H; Wang Q; Sha W
    Int J Mol Med; 2016 Oct; 38(4):1199-207. PubMed ID: 27600678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway.
    Shen T; Yang Z; Cheng X; Xiao Y; Yu K; Cai X; Xia C; Li Y
    Oncol Rep; 2017 Apr; 37(4):2095-2100. PubMed ID: 28259918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen‑like‑protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.
    Zhang Y; Qiao HX; Zhou YT; Hong L; Chen JH
    Mol Med Rep; 2018 Aug; 18(2):1465-1472. PubMed ID: 29845203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of STC2 gene silencing on colorectal cancer cells.
    Li Q; Zhou X; Fang Z; Pan Z
    Mol Med Rep; 2019 Aug; 20(2):977-984. PubMed ID: 31173256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C086, a novel analog of curcumin, induces growth inhibition and down-regulation of NFκB in colon cancer cells and xenograft tumors.
    Chen C; Liu Y; Chen Y; Xu J
    Cancer Biol Ther; 2011 Nov; 12(9):797-807. PubMed ID: 21900746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DDA1 promotes stage IIB-IIC colon cancer progression by activating NFκB/CSN2/GSK-3β signaling.
    Zhao S; Tang H; Yan D; Fan J; Sun H; Wen Y; Yu F; Cui F; Zhang D; Xue Y; Liu C; Yue B; Chen J; Wang J; Wang X; Zhang M; Yu Y; Jiang W; Liu X; Mi Y; Zhou Z; Qin X; Peng Z
    Oncotarget; 2016 Apr; 7(15):19794-812. PubMed ID: 26942699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer.
    Huang Z; Ai Z; Li N; Xi H; Gao X; Wang F; Tan X; Liu H
    Cancer Biomark; 2016; 17(4):445-455. PubMed ID: 28085015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer.
    Negri F; Bozzetti C; Pedrazzi G; Azzoni C; Bottarelli L; Squadrilli A; Lagrasta C; Tamagnini I; Bisagni A; Ragazzi M; Porzio R; Tomasello G; Mori D; Leonardi F; Gnetti L; Crafa P; Sala R; Cascinu S
    Oncol Rep; 2019 Dec; 42(6):2750-2758. PubMed ID: 31578584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.